This website is intended for healthcare professionals only
Specialities

Specialities

Acne
Aesthetic and Cosmetic Dermatology
Allergic and Immunologic Conditions
Cutaneous Oncology and Oncodermatology
Dermatopathology and Diagnostics
General Medical Dermatology
Global Dermatology and Public Health
Hair, Scalp and Nail Disorders
Infectious Dermatology
Inflammatory and Autoimmune Diseases
Pediatric Skin Conditions
Pigmentation Disorders
Procedural and Surgical Dermatology
Rare Skin Conditions
Search

Trending Topic

BADBIR Zenas Yiu psoriasis treatment real world
7 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

BAD 2026: BADBIR data offer real-world insights into psoriasis treatment and risk factors

Zenas Yiu

At the BAD 2026 meeting, new analyses from BADBIR highlighted the value of real-world evidence in answering clinically important questions in psoriasis care. The data explored serious infection risk across systemic treatments, the potential benefits of using biologics earlier in the treatment pathway, and risk factors for incident and recurrent erythrodermic psoriasis. Together, these findings demonstrate how registry data can complement clinical trial evidence by providing insights from routine clinical practice and helping to inform more personalized treatment decisions.

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

XV International Congress of Dermatology 2029

XV International Congress of Dermatology 2029
Web Address: ICD2029

XV International Congress of Dermatology (ICD 2029)

The International Society of Dermatology (ISD) is thrilled to announce that the XV International Congress of Dermatology 2029 will be held in Shanghai from 14-17 June 2029!

Shanghai, a vibrant global hub renowned for cutting-edge medical research, rich culture, and world-class conference facilities, is the perfect city to unite our international dermatology community.

We can’t wait to see you in Shanghai in 2029!

Further Resources

  1. XV International Congress of Dermatology (ICD 2029)
BADBIR Zenas Yiu psoriasis treatment real world

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

BAD 2026: BADBIR data offer real-world insights into psoriasis treatment and risk factors

Zenas Yiu

At the BAD 2026 meeting, new analyses from BADBIR highlighted the value of real-world evidence in answering clinically important questions in psoriasis care. The data explored serious infection risk across systemic treatments, the potential benefits of using biologics earlier in the treatment pathway, and risk factors for incident and recurrent erythrodermic psoriasis. Together, these findings demonstrate how registry data can complement clinical trial evidence by providing insights from routine clinical practice and helping to inform more personalized treatment decisions.

Advertisement

    • Latest articles videos and clinical updates - straight to your inbox

    Close Popup